Search research articles
Contact Us
Filters
Showing results (131-140 of 194) with videos related to
Page
of 20
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 1, 1990
Phase II trial of carboplatin in the management of malignant mesothelioma
D Raghavan, P Gianoutsos, J Bishop, et al.
Seminars in Oncology
|
October 1, 1995
Phase I study of paclitaxel and carboplatin: implications for trials in head and neck cancer
P Creaven, D Raghavan, L Pendyala, et al.
The Annals of Thoracic Surgery
|
April 1, 1982
Mediastinal nonseminomatous germ cell tumors: the role of combined modality therapy
N J Vogelzang, D Raghavan, R W Anderson, et al.
The Medical Journal of Australia
|
May 18, 1992
Combination chemotherapy with cisplatin, vindesine and mitomycin-C for advanced, inoperable non-small-cell lung cancer
M Stockler, D Raghavan, B C McCaughan, et al.
Journal of Clinical Pathology
|
February 1, 1981
Hypothesis: when is a seminoma not a seminoma?
D Raghavan, E Heyderman, P Monaghan, et al.
Urological Research
|
January 1, 1988
Features of squamous and adenocarcinoma in the same cell in a xenografted human transitional cell carcinoma: evidence of a common histogenesis?
P J Russell, E J Wills, J Philips, et al.
The Medical Journal of Australia
|
March 3, 1984
Intravenous cis-platinum for invasive bladder cancer. Safety and feasibility of a new approach
D Raghavan, B Pearson, G Coorey, et al.
Progress in Clinical and Biological Research
|
January 1, 1986
Experimental models of bladder cancer: a critical review
D Raghavan, F Debruyne, H Herr, et al.
Australian and New Zealand Journal of Medicine
|
December 1, 1983
The role of hepatitis B virus in the etiology of hepatocellular carcinoma in Australia
A G Dalgleish, R L Woods, J A Levi, et al.
The British Journal of Cancer. Supplement
|
April 1, 1980
The interpretation of marker protein assays: a critical appraisal in clinical studies and a xenograft model
D Raghavan, J Gibbs, R Nogueira Costa, et al.
Page
of 20
Search research articles
Search
Showing results (131-140 of 194) with videos related to
Sort By:
Page
of 20
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 1, 1990
Phase II trial of carboplatin in the management of malignant mesothelioma
D Raghavan, P Gianoutsos, J Bishop, et al.
Seminars in Oncology
|
October 1, 1995
Phase I study of paclitaxel and carboplatin: implications for trials in head and neck cancer
P Creaven, D Raghavan, L Pendyala, et al.
The Annals of Thoracic Surgery
|
April 1, 1982
Mediastinal nonseminomatous germ cell tumors: the role of combined modality therapy
N J Vogelzang, D Raghavan, R W Anderson, et al.
The Medical Journal of Australia
|
May 18, 1992
Combination chemotherapy with cisplatin, vindesine and mitomycin-C for advanced, inoperable non-small-cell lung cancer
M Stockler, D Raghavan, B C McCaughan, et al.
Journal of Clinical Pathology
|
February 1, 1981
Hypothesis: when is a seminoma not a seminoma?
D Raghavan, E Heyderman, P Monaghan, et al.
Urological Research
|
January 1, 1988
Features of squamous and adenocarcinoma in the same cell in a xenografted human transitional cell carcinoma: evidence of a common histogenesis?
P J Russell, E J Wills, J Philips, et al.
The Medical Journal of Australia
|
March 3, 1984
Intravenous cis-platinum for invasive bladder cancer. Safety and feasibility of a new approach
D Raghavan, B Pearson, G Coorey, et al.
Progress in Clinical and Biological Research
|
January 1, 1986
Experimental models of bladder cancer: a critical review
D Raghavan, F Debruyne, H Herr, et al.
Australian and New Zealand Journal of Medicine
|
December 1, 1983
The role of hepatitis B virus in the etiology of hepatocellular carcinoma in Australia
A G Dalgleish, R L Woods, J A Levi, et al.
The British Journal of Cancer. Supplement
|
April 1, 1980
The interpretation of marker protein assays: a critical appraisal in clinical studies and a xenograft model
D Raghavan, J Gibbs, R Nogueira Costa, et al.
Page
of 20